Monoclonal Antibody | Sources | Treatment | References |
Bamlanivimab plus etesevimab | Derived from the blood of one of the first U.S. patients who recovered from COVID-19. | SARS-CoV-2 and mild to moderate covid-19 patient. | [21] [22] |
Casirivimab plus imdevimab | Type of protein derived from Monoclonal antibody | For treatment and prevention of Covid-19. SARS CoV & SARS Cov-2 | [23] [24] |
Sotrovimab | Chinese hamster ovary cells | COVID-19 in adults & pediatric patients 12 years of age and older weighing at least 40 kg with positive results of direct SARS-CoV-2 viral testing | [25] |